Search research articles
Contact Us
Filters
Showing results (291-300 of 345) with videos related to
Page
of 35
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 7, 2025
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates
Erik S Pena, Luis Ontiveros-Padilla, Nicole R Lukesh, et al.
Human Vaccines & Immunotherapeutics
|
January 12, 2016
Are plasma mineral levels related to antibody response to influenza vaccination in older adults?
Ata Murat Kaynar, Mary Patricia Nowalk, Chyongchiou Jeng Lin, et al.
Human Vaccines & Immunotherapeutics
|
March 12, 2014
Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age
Ted M Ross, Chyongchiou Jeng Lin, Mary Patricia Nowalk, et al.
Frontiers in Immunology
|
May 8, 2023
Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants
Meagan M Jenkins, Donna Phan Tran, Evelyn A Flores, et al.
Advanced Therapeutics
|
March 6, 2026
COBRA Hemagglutinin and cGAMP Loaded Ace-DEX Microparticles Provide a Broadly Active and Shelf-Stable Influenza Vaccine Platform
Dylan A Hendy, Erik S Pena, Cole J Batty, et al.
Journal of Virology
|
February 26, 2016
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M Carter, Christopher A Darby, Bradford C Lefoley, et al.
Scientific Reports
|
March 4, 2022
Clinical validation of a multiplex PCR-based detection assay using saliva or nasopharyngeal samples for SARS-Cov-2, influenza A and B
Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, et al.
Journal of Virology
|
May 31, 2024
Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses"
Donald M Carter, Christopher A Darby, Bradford C Lefoley, et al.
The American Journal of Pathology
|
November 5, 2013
Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection
Radha Gopal, Javier Rangel-Moreno, Beth A Fallert Junecko, et al.
The Journal of Molecular Diagnostics : JMD
|
May 6, 2021
Clinical Validation of a Sensitive Test for Saliva Collected in Healthcare and Community Settings with Pooling Utility for Severe Acute Respiratory Syndrome Coronavirus 2 Mass Surveillance
Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 345) with videos related to
Sort By:
Page
of 35
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 7, 2025
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates
Erik S Pena, Luis Ontiveros-Padilla, Nicole R Lukesh, et al.
Human Vaccines & Immunotherapeutics
|
January 12, 2016
Are plasma mineral levels related to antibody response to influenza vaccination in older adults?
Ata Murat Kaynar, Mary Patricia Nowalk, Chyongchiou Jeng Lin, et al.
Human Vaccines & Immunotherapeutics
|
March 12, 2014
Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age
Ted M Ross, Chyongchiou Jeng Lin, Mary Patricia Nowalk, et al.
Frontiers in Immunology
|
May 8, 2023
Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants
Meagan M Jenkins, Donna Phan Tran, Evelyn A Flores, et al.
Advanced Therapeutics
|
March 6, 2026
COBRA Hemagglutinin and cGAMP Loaded Ace-DEX Microparticles Provide a Broadly Active and Shelf-Stable Influenza Vaccine Platform
Dylan A Hendy, Erik S Pena, Cole J Batty, et al.
Journal of Virology
|
February 26, 2016
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M Carter, Christopher A Darby, Bradford C Lefoley, et al.
Scientific Reports
|
March 4, 2022
Clinical validation of a multiplex PCR-based detection assay using saliva or nasopharyngeal samples for SARS-Cov-2, influenza A and B
Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, et al.
Journal of Virology
|
May 31, 2024
Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses"
Donald M Carter, Christopher A Darby, Bradford C Lefoley, et al.
The American Journal of Pathology
|
November 5, 2013
Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection
Radha Gopal, Javier Rangel-Moreno, Beth A Fallert Junecko, et al.
The Journal of Molecular Diagnostics : JMD
|
May 6, 2021
Clinical Validation of a Sensitive Test for Saliva Collected in Healthcare and Community Settings with Pooling Utility for Severe Acute Respiratory Syndrome Coronavirus 2 Mass Surveillance
Nikhil S Sahajpal, Ashis K Mondal, Sudha Ananth, et al.
Page
of 35